Literature DB >> 1635731

The significance of peritoneal cytology in stage IB cervical cancer.

P C Morris1, J Haugen, B Anderson, R Buller.   

Abstract

OBJECTIVE: The purpose of this study was to determine the incidence of positive peritoneal cytology and to evaluate its usefulness in the management of patients with early-stage cervical cancer.
METHODS: Peritoneal cytology was studied in 273 women undergoing primary surgical exploration for International Federation of Gynecology and Obstetrics stage IB cancer of the cervix. Charts were reviewed retrospectively for clinicopathologic data concerning tumor size, cell type, lymph node status, and outcome.
RESULTS: Cytology was positive in four women, three of whom had enlarged pelvic or para-aortic lymph nodes or intraperitoneal disease. There was no association between tumor histology or tumor size and peritoneal cytology.
CONCLUSION: The incidence of positive peritoneal cytology in early-stage cervical cancer is low, and the prognostic significance of positive cytology is overshadowed by other risk factors more obvious at surgery. The routine collection of cytologic specimens at laparotomy should be abandoned in this setting.

Entities:  

Mesh:

Year:  1992        PMID: 1635731

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer.

Authors:  Shiho Kuji; Yasuyuki Hirashima; Satomi Komeda; Aki Tanaka; Masakazu Abe; Nobutaka Takahashi; Munetaka Takekuma
Journal:  J Gynecol Oncol       Date:  2014-04-09       Impact factor: 4.401

Review 2.  Diagnostic Cytopathology of Peritoneal Washings.

Authors:  Rosemary E Zuna
Journal:  Cytojournal       Date:  2022-02-28       Impact factor: 2.345

3.  The impact of positive peritoneal cytology on prognosis in patients with cervical cancer: a meta-analysis.

Authors:  Sang-Hee Yoon; Soo-Nyung Kim; Seung-Hyuk Shim; Ji-Young Lee; Sun-Joo Lee; In-Kyeong Oh; Hyeon-Jeong Kim; Soon-Beom Kang
Journal:  Br J Cancer       Date:  2015-07-30       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.